x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as

science & medicine medicine

All Episodes

00:00:00

Case Study: Relatively Late Diagnosis & Management of...

Global Neurology Academy ·

2023/05/26

Guest: Jeffrey L. Neul, MD, PhD Rett Syndrome (RTT) is an X-linked dominant genetic disease estimated to affect one in every 10,000 to 15,000 live female births across all racial and ethnic groups. It is the second most common cause of mental disability in females. RTT is associated with a spectrum of subtle symptoms, many of which manifest during specific ages during a child's development. Delayed diagnosis of RTT is very common. The inability to differentiate the subtle signs of RTT

en

00:00:00

Compassionate Communication: Keeping the Patient and...

Global Neurology Academy ·

2023/05/26

Guest: Alan K. Percy, MD Rett Syndrome (RTT) is an X-linked dominant genetic disease estimated to affect one in every 10,000 to 15,000 live female births across all racial and ethnic groups. It is the second most common cause of mental disability in females. RTT is associated with a spectrum of subtle symptoms, many of which manifest during specific ages during a child's development. Delayed diagnosis of RTT is very common. The inability to differentiate the subtle signs of RTT impedes

en

00:00:00

Quarterbacking the Interprofessional Team: Optimizing...

Global Neurology Academy ·

2023/05/26

Guest: Alan K. Percy, MD Rett Syndrome (RTT) is an X-linked dominant genetic disease estimated to affect one in every 10,000 to 15,000 live female births across all racial and ethnic groups. It is the second most common cause of mental disability in females. RTT is associated with a spectrum of subtle symptoms, many of which manifest during specific ages during a child's development. Delayed diagnosis of RTT is very common. The inability to differentiate the subtle signs of RTT impedes

en

00:00:00

Understanding the Fine Print: The Who, When, And What...

Global Neurology Academy ·

2023/05/15

Host: James Galvin, MD, MPH, FANA Guest: Gloria Chiang, MD Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF Guest: Charles P. Vega, MD Recently, Alzheimer’s Disease (AD) saw its first approvals for disease-modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are

en

00:00:00

Expert Recommended Best Practices: Treatment...

Global Neurology Academy ·

2023/04/28

Host: Daniel Kremens, MD, JD Guest: Rajesh Pahwa, MD Guest: Stuart H. Isaacson, MD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients

en

00:00:00

The Building Blocks: Early Recognition, Assessment,...

Global Neurology Academy ·

2023/04/28

Host: Daniel Kremens, MD, JD Guest: Rajesh Pahwa, MD Guest: Stuart H. Isaacson, MD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients

en

00:00:00

Case Study: Aunt Judy Has Been Hallucinating -...

Global Neurology Academy ·

2023/04/28

Guest: Stuart H. Isaacson, MD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients and causes a substantial burden to the patient and their care

en

00:00:00

Routine Screening for Psychotic Symptoms in...

Global Neurology Academy ·

2023/04/28

Guest: Daniel Kremens, MD, JD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients and causes a substantial burden to the patient and their care

en

00:00:00

Psychotic Symptoms in Parkinson’s Disease Psychosis...

Global Neurology Academy ·

2023/04/28

Guest: Stuart H. Isaacson, MD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients and causes a substantial burden to the patient and their care

en

00:00:00

Parkinson’s Disease Psychosis: A Case of Delusions,...

Global Neurology Academy ·

2023/04/28

Guest: Daniel Kremens, MD, JD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients and causes a substantial burden to the patient and their care

en

00:00:00

Develop the Plan, Work the Plan: Integrating Ongoing...

Global Neurology Academy ·

2023/04/28

Guest: Rajesh Pahwa, MD Parkinson’s Disease Psychosis (PDP) is a chronic, severely debilitating, and progressive neurodegenerative illness. PDP was once believed to be primarily a motor dysfunction disease, but it is now known to be multifaceted, encompassing cognitive and neuropsychiatric complications. PDP, which may include visual phenomena, hallucinations, and delusions, has been reported in up to 60% of patients and causes a substantial burden to the patient and their care

en

00:00:00

Special Report: Management Considerations and Unmet...

Global Neurology Academy ·

2023/04/17

Host: Nilika Singhal, MD Guest: M. Scott Perry, MD Guest: Elizabeth Anne Thiele, MD, PhD Lennox-Gastaut syndrome and Dravet syndrome are 2 rare epileptic disorders with a pediatric onset. They‘re often refractory to therapy and have significant side effects due to polytherapy. Listen in as Drs. Nilika Singhal, Elizabeth Thiele, and M. Scott Perry discuss treatment options and how you can lessen the impact of polypharmacy on your patients.

en

00:00:00

The Future of Multiple Sclerosis Patient Care:...

Global Neurology Academy ·

2023/04/03

Guest: Shibeshih Belachew, MD PhD Host: Charles Turck, PharmD, BCPS, BCCCP Technology is advancing exponentially, and this has been more evident than ever in the field of medicine. In fact, biotech and pharmaceutical companies are bringing biology and technology together to better meet patient needs across a range of specialties. So what are the latest research and initiatives in digital health that are working towards a future of more personalized medicine for patients with

en

00:00:00

Schizophrenia and Bipolar Disorder: Improving...

Global Neurology Academy ·

2023/03/22

Host: John Russell, MD Guest: Joseph F. Goldberg, MD Schizophrenia affects an estimated 21 million people worldwide, and bipolar disorder (BPD) is the sixth leading cause of disability. These are chronic psychiatric illnesses that require long-term care, and place significant health and economic burdens on patients and their families. In recent decades, the distinct separation of these two illnesses has weakened, and the medical literature now recognizes a partial genetic overlap

en

00:00:00

Battle of the Biomarkers: Assessing Key Factors in...

Global Neurology Academy ·

2023/03/21

Host: Robert Shin, MD, FANA, FAAN Guest: Jiwon Oh, MD, PhD, FRCPC Guest: Enrique Alvarez, MD, PhD Over the past several years, the image of MS has been changing from distinct categories of disease to a complicated spectrum of interwoven pathologies. As this knowledge evolves, so do approaches to prognosticating, monitoring, and responding to disease. With many markers of progression still under investigation and therefore not included in modern guidelines, MS clinicians are

en

00:00:00

Advances in Temporal Lobe Epilepsy Research

Global Neurology Academy ·

2022/08/29

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Sanjay Kumar, PhD Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy. Due to recent research from Florida State University, we might have a better understanding of the potential link between a specific protein and increased vulnerability to neurodegeneration among patients with this disorder. Dr. Andrew Wilner is joined by Dr. Sanjay Kumar, Professor of

en

00:00:00

AI in Neurology: What Tools Are Emerging?

Global Neurology Academy ·

2022/06/30

Host: Jerome Lisk, MD Guest: Mark Mintz, MD Recent developments in artificial intelligence (AI) technology have shown to aid with neurological disease diagnosis, risk stratification, treatment response, and more. So what are the newest AI applications? And perhaps even more importantly, what’s to come in the future? To find out the answer to these and other key questions, Dr. Jerome Lisk speaks with Dr. Mark Mintz, Chief Medical Officer and Founder of NeurAbilities Healthcare, to

en

00:00:00

Investigating the Link Between Hypertension...

Global Neurology Academy ·

2022/05/23

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Zachary Marcum, PharmD, PhD Hypertension affects nearly half of adults in the United States and is associated with cognitive decline and dementia. A wide variety of antihypertensive medications are prescribed to millions of people to control blood pressure and prevent vascular dementia. Could it be that certain medications are better than others in preventing brain injury

en

00:00:00

B-Cell Therapy: When Is It Right for Our MS Patients?

Global Neurology Academy ·

2022/05/19

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Chan, MD Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple sclerosis (MS), but their exact role is unclear. Despite that uncertainty, B-cell depletion therapies have shown to ease symptoms, prevent relapses, and even slow the course of the disease. So how exactly do B-cell therapies work, and how do we know if they’re right for our patients? Joining Dr. Charles Turck to talk about the role

en

00:00:00

Alzheimer’s Disease: What’s The Latest Research?

Global Neurology Academy ·

2022/04/26

Host: Jerome Lisk, MD Guest: Peter Whitehouse, MD, PhD Guest: Daniel George, MSc, PhD Although there’s still no cure for Alzheimer’s disease, we’ve made great strides in understanding the tragic disease that affects more than 50 million people worldwide. So what are the latest updates in treating and alleviating this disease? To learn more about what’s new in Alzheimer’s disease research, Dr. Jerome Lisk speaks with Dr. Peter Whitehouse and Dr. Daniel George, co-authors of

en

87 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事